Huriez syndrome
hyur-ee-ayz sin-drohm
Also known as: sclerotylosis, Palmoplantar keratoderma with sclerodactyly
At a Glance
What is Huriez syndrome?
Huriez syndrome is a rare genetic disorder that primarily affects the skin and nails. It is characterized by a combination of palmoplantar keratoderma, which is thickening of the skin on the palms and soles, and sclerodactyly, which involves thickening and tightening of the skin on the fingers. The condition is caused by mutations in the SMARCAD1 gene, which affects skin development and maintenance. Over time, individuals with Huriez syndrome may experience increased risk of skin cancers, particularly squamous cell carcinoma. Early symptoms often include dry, thickened skin on the hands and feet, while later symptoms can involve more severe skin changes and potential malignancies. Early diagnosis is critical to manage symptoms and monitor for cancerous changes. The condition can impact family life due to its genetic nature, requiring genetic counseling and monitoring of family members. Prognosis varies depending on the severity of skin involvement and the development of skin cancer. Daily life for affected individuals may involve regular dermatological care and protective measures against skin damage. The disorder can also cause social and emotional challenges due to visible skin changes. Management typically involves a multidisciplinary approach to address both dermatological and oncological concerns.
Medical Definition
Huriez syndrome is a rare autosomal dominant genetic disorder characterized by palmoplantar keratoderma and sclerodactyly. Pathologically, it involves mutations in the SMARCAD1 gene, leading to abnormal skin development and increased cancer risk. Histologically, affected skin shows hyperkeratosis and fibrosis. It is classified under genetic dermatological disorders with potential oncological implications. Epidemiologically, it is extremely rare, with an estimated prevalence of 1 in 1,000,000. The disease course involves progressive skin changes and a significant risk of developing squamous cell carcinoma.
Huriez syndrome Symptoms
Symptoms vary in severity between individuals. Early diagnosis and management can significantly improve outcomes.
Very Common
Sclerodactyly manifests as thickening and tightening of the skin on the fingers. This occurs due to excessive collagen deposition in the skin layers. Over time, it can lead to reduced mobility and deformities in the fingers. Daily activities such as writing or buttoning a shirt become challenging, and physical therapy can help maintain function.
Palmoplantar keratoderma presents as thickened skin on the palms and soles. It is caused by abnormal keratinization of the skin cells. The condition can worsen with age, leading to painful fissures and difficulty walking. Regular moisturizing and keratolytic agents can alleviate discomfort and improve skin flexibility.
Hypoplastic nails are underdeveloped and may appear thin or small. This is due to disrupted nail matrix development. The condition is usually stable but can lead to increased nail fragility and breakage. Protective nail care and avoiding trauma can help manage this symptom.
Common
Individuals with Huriez syndrome have a heightened risk of developing skin cancer, particularly squamous cell carcinoma. This is attributed to genetic mutations affecting skin cell regulation. The risk increases with age and cumulative sun exposure. Regular dermatological check-ups and sun protection are crucial preventive measures.
Skin atrophy is characterized by thinning of the skin, making it appear fragile and translucent. It results from the loss of collagen and elastin fibers. Over time, this can lead to increased susceptibility to injuries and bruising. Gentle skin care and avoiding harsh chemicals can help protect the skin.
Photosensitivity causes the skin to react abnormally to sunlight, leading to rashes or burns. This occurs due to heightened sensitivity of the skin cells to UV radiation. It can worsen with prolonged sun exposure, causing discomfort and skin damage. Protective clothing and broad-spectrum sunscreen are essential for management.
Less Common
Hair abnormalities may include sparse or brittle hair. These changes are due to alterations in hair follicle structure and function. The condition is generally stable but can affect self-esteem and appearance. Hair care products designed for sensitive hair and regular trims can help manage this symptom.
Delayed wound healing is observed as prolonged recovery time for cuts and abrasions. This is caused by impaired skin repair mechanisms. Over time, this can lead to increased risk of infections and scarring. Proper wound care and monitoring for signs of infection are important for management.
What Causes Huriez syndrome?
Huriez syndrome is primarily caused by mutations in the SMARCAD1 gene, located on chromosome 4q22.3. The SMARCAD1 gene encodes a protein involved in chromatin remodeling, which is crucial for DNA repair and transcriptional regulation. Mutations in SMARCAD1, particularly large deletions, disrupt the skin-specific isoform of the protein, impairing its normal function. This disruption leads to defective chromatin remodeling, affecting gene expression and cellular responses to DNA damage. As a result, there is a dysfunction in the cellular pathways responsible for maintaining skin integrity and immune regulation. The impaired chromatin remodeling can also lead to abnormal signaling in neighboring cells, contributing to tissue-specific manifestations. Neuroinflammation and immune dysregulation may exacerbate the condition, as the immune system may inappropriately target affected skin cells. This can lead to degeneration of skin structures, particularly in areas exposed to mechanical stress or UV radiation. Symptoms such as sclerodactyly and palmoplantar keratoderma appear due to the specific vulnerability of skin tissues to these molecular disruptions. The variability in disease severity among patients can be attributed to the type of mutation, the extent of chromatin remodeling impairment, and individual genetic backgrounds. Additionally, the risk of squamous cell carcinoma is increased due to the compromised DNA repair mechanisms. The pattern of symptoms reflects the combined effects of genetic, environmental, and immunological factors. Understanding these molecular and cellular mechanisms is crucial for developing targeted therapies for Huriez syndrome.
How is Huriez syndrome Diagnosed?
Typical age of diagnosis: Huriez syndrome is typically diagnosed in early childhood when characteristic skin changes become apparent. Parents often notice unusual skin texture and color in their child's hands and feet. The syndrome may be suspected when these symptoms are accompanied by nail abnormalities and sclerodactyly. Early diagnosis is crucial for managing potential complications such as skin cancer.
The clinician looks for characteristic skin changes such as palmoplantar keratoderma and sclerodactyly. A detailed family history is crucial, as Huriez syndrome is inherited in an autosomal dominant pattern. Physical examination reveals thickened skin on the palms and soles, nail dystrophy, and possible hypopigmentation. This step helps differentiate Huriez syndrome from other scleroderma-like conditions.
High-resolution ultrasound or MRI may be used to assess skin and soft tissue involvement. Imaging can reveal subcutaneous tissue thickening and exclude other connective tissue disorders. Findings support the diagnosis by showing characteristic skin changes without systemic organ involvement. Imaging helps rule out differential diagnoses such as systemic sclerosis.
Routine blood tests are typically normal, but specific tests may include autoantibody panels. Biomarkers such as ANA and anti-Scl-70 are usually absent, helping to exclude systemic sclerosis. Abnormal results are not expected, as Huriez syndrome primarily affects the skin. Laboratory tests guide clinicians to focus on genetic testing for confirmation.
Genetic testing focuses on sequencing the SMARCAD1 gene. Mutations such as large deletions affecting the skin-specific isoform are commonly identified. Positive results confirm the diagnosis of Huriez syndrome and differentiate it from other genodermatoses. Genetic findings are essential for family counseling and assessing recurrence risk.
Huriez syndrome Treatment Options
Emollients and keratolytics are used to manage skin symptoms by softening and exfoliating thickened skin. Commonly used agents include urea-based creams and salicylic acid. Clinical evidence suggests these treatments improve skin texture and reduce discomfort. However, they do not prevent potential malignant transformation. Side effects may include skin irritation or allergic reactions.
Physical therapy focuses on maintaining joint mobility and preventing contractures. Techniques include stretching exercises and manual therapy. Sessions are typically conducted weekly, with duration adjusted based on individual progress. Measurable outcomes include improved range of motion and reduced stiffness. Long-term benefits include enhanced functional ability and quality of life.
Surgery is indicated for the removal of suspicious or cancerous skin lesions. The procedure involves excising the lesion with clear margins to prevent recurrence. Expected benefits include reduced risk of squamous cell carcinoma. Surgical risks include infection, scarring, and potential need for skin grafts. Post-operative care involves wound management and regular follow-up.
The care team includes dermatologists, geneticists, and physical therapists. Interventions focus on skin care, genetic counseling, and rehabilitation. Psychosocial support strategies involve counseling and support groups for patients and families. Family education covers disease management and monitoring for complications. Long-term monitoring includes regular skin checks and functional assessments.
When to See a Doctor for Huriez syndrome
- Rapidly growing skin lesion — this could indicate squamous cell carcinoma, a known risk in Huriez syndrome.
- Severe skin infection — untreated infections can lead to systemic complications.
- Sudden loss of sensation in limbs — may indicate nerve involvement requiring urgent evaluation.
- Persistent skin thickening — may suggest progression of the condition, requiring dermatological assessment.
- New onset of skin ulcers — could indicate complications needing medical attention.
- Changes in nail appearance — may signify disease progression or secondary conditions.
- Mild skin dryness — monitor for worsening and apply emollients.
- Occasional joint stiffness — monitor for increased frequency or severity.
Huriez syndrome — Frequently Asked Questions
Is this condition hereditary?
Huriez syndrome is inherited in an autosomal dominant pattern, meaning one copy of the altered gene is sufficient to cause the disorder. There is a 50% chance of passing the condition to offspring if one parent is affected. De novo mutations are rare but possible. Carriers of the gene mutation may exhibit some symptoms. Genetic counseling is recommended for affected individuals and their families.
What is the life expectancy for someone with this condition?
Life expectancy can vary depending on the age of onset and severity of symptoms. Early diagnosis and management of skin cancer risks can improve outcomes. Mortality is often related to complications such as squamous cell carcinoma. Effective treatment and regular monitoring can enhance survival rates. Patients should have realistic expectations regarding chronic management and potential complications.
How is this condition diagnosed and how long does diagnosis take?
Diagnosis involves clinical evaluation, family history assessment, and genetic testing. The time from first symptoms to diagnosis can vary, often taking several months. Dermatologists and geneticists are typically consulted. Delayed diagnosis may occur due to symptom overlap with other skin conditions. Genetic testing confirming SMARCAD1 mutations finalizes the diagnosis.
Are there any new treatments or clinical trials available?
Research is ongoing, with some promising studies focusing on gene therapy. Novel approaches include targeting the genetic basis of the condition. Clinical trials can be found on ClinicalTrials.gov by searching for Huriez syndrome. Patients should discuss potential trial participation with their doctor. New treatments may become available in the next few years, but timelines are uncertain.
How does this condition affect daily life and activities?
Huriez syndrome can impact mobility due to skin stiffness and joint involvement. Educational adjustments may be necessary for children with the condition. Social and emotional challenges include coping with visible skin changes. Family support is crucial, as the condition can be burdensome. Adaptive aids and community resources can significantly improve quality of life.
Learn More
Support & Resources
References
Content generated with support from peer-reviewed literature via PubMed.
- 1.Huriez Syndrome.
Singh S, Das S · Indian Dermatol Online J · 2025 · PMID: 40709887
- 2.Huriez Syndrome and SCC Risk: A Narrative Review Highlighting Surgical Challenges and Oncologic Considerations.
Pagnotta A, Patanè L, Zoccali C et al. · J Clin Med · 2025 · PMID: 40806836
- 3.Huriez syndrome: Additional pathogenic variants supporting allelism to SMARCAD syndrome.
Loh AYT, Špoljar S, Neo GYW et al. · Am J Med Genet A · 2022 · PMID: 35212137
- 4.Clinical images: Huriez syndrome, a rare scleroderma mimic.
Mukherjee S, Maurya MK, Kumar P · Arthritis Rheumatol · 2022 · PMID: 35606925
- 5.Claude Huriez and his syndrome.
Al Aboud K, Khachemoune A · Skinmed · 2011 · PMID: 22165047
- 6.Huriez syndrome associated with basal cell carcinoma. A case report.
Grigatti M, Pescarini E, Salmaso R et al. · Ann Ital Chir · 2020 · PMID: 32690823
- 7.Huriez syndrome caused by a large deletion that abrogates the skin-specific isoform of SMARCAD1.
Loh AYT, Ho CM, Muthiah S et al. · Br J Dermatol · 2021 · PMID: 33400266
- 8.A Rare Syndrome Resembling Scleroderma: Huriez Syndrome.
Çelik NS, Yaşar Ş, Aytekin S et al. · Skin Appendage Disord · 2018 · PMID: 29765964
This content is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.Last reviewed: 2026-06-05